Cargando…

Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis

Frontotemporal Dementia (FTD) is a common cause of Young Onset Dementia and has diverse clinical manifestations involving behavior, executive function, language and motor function, including parkinsonism. Up to 50% of FTD patients report a positive family history, supporting a strong genetic basis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Dominguez, Jacqueline, Yu, Jeryl Tan, Tan, Yi Jayne, Ng, Arlene, De Guzman, Ma Fe, Natividad, Boots, Daroy, Ma Luisa, Cano, Jemellee, Yu, Justine, Lian, Michelle M., Zeng, Li, Lim, Weng Khong, Foo, Jia Nee, Ng, Adeline S. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170397/
https://www.ncbi.nlm.nih.gov/pubmed/34093394
http://dx.doi.org/10.3389/fneur.2021.645913
_version_ 1783702234557579264
author Dominguez, Jacqueline
Yu, Jeryl Tan
Tan, Yi Jayne
Ng, Arlene
De Guzman, Ma Fe
Natividad, Boots
Daroy, Ma Luisa
Cano, Jemellee
Yu, Justine
Lian, Michelle M.
Zeng, Li
Lim, Weng Khong
Foo, Jia Nee
Ng, Adeline S. L.
author_facet Dominguez, Jacqueline
Yu, Jeryl Tan
Tan, Yi Jayne
Ng, Arlene
De Guzman, Ma Fe
Natividad, Boots
Daroy, Ma Luisa
Cano, Jemellee
Yu, Justine
Lian, Michelle M.
Zeng, Li
Lim, Weng Khong
Foo, Jia Nee
Ng, Adeline S. L.
author_sort Dominguez, Jacqueline
collection PubMed
description Frontotemporal Dementia (FTD) is a common cause of Young Onset Dementia and has diverse clinical manifestations involving behavior, executive function, language and motor function, including parkinsonism. Up to 50% of FTD patients report a positive family history, supporting a strong genetic basis, particularly in cases with both FTD and amyotrophic lateral sclerosis (FTD-ALS). Mutations in three genes are associated with the majority of familial FTD (fFTD) cases - microtubule associated protein tau gene (MAPT), granulin precursor (GRN), and hexanucleotide repeat expansions in chromosome 9 open reading frame 72- SMCR8complex subunit (C9orf72) while mutations in other genes such as optineurin (OPTN) have rarely been reported. Mutations in OPTN have been reported mostly in familial and sporadic cases of ALS, or in rare cases of FTD-ALS, but not in association with pure or predominant FTD and/or parkinsonian phenotype. Here, we report for the first time, a family from the Philippines with four members harboring a novel frameshift insertion at OPTN (Chr 10:13166090 G>GA) p.Lys328GluTer11, three of whom presented with FTD-related phenotypes. Additionally, one sibling heterozygous for the frameshift insertion had a predominantly parkinsonian phenotype resembling corticobasal syndrome, but it remains to be determined if this phenotype is related to the frameshift insertion. Notably, none of the affected members showed any evidence of motor neuron disease or ALS at the time of writing, both clinically and on electrophysiological testing, expanding the phenotypic spectrum of OPTN mutations. Close follow-up of mutation carriers for the development of new clinical features and wider investigation of additional family members with further genetic analyses will be conducted to investigate the possibility of other genetic modifiers in this family which could explain phenotypic heterogeneity.
format Online
Article
Text
id pubmed-8170397
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81703972021-06-03 Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis Dominguez, Jacqueline Yu, Jeryl Tan Tan, Yi Jayne Ng, Arlene De Guzman, Ma Fe Natividad, Boots Daroy, Ma Luisa Cano, Jemellee Yu, Justine Lian, Michelle M. Zeng, Li Lim, Weng Khong Foo, Jia Nee Ng, Adeline S. L. Front Neurol Neurology Frontotemporal Dementia (FTD) is a common cause of Young Onset Dementia and has diverse clinical manifestations involving behavior, executive function, language and motor function, including parkinsonism. Up to 50% of FTD patients report a positive family history, supporting a strong genetic basis, particularly in cases with both FTD and amyotrophic lateral sclerosis (FTD-ALS). Mutations in three genes are associated with the majority of familial FTD (fFTD) cases - microtubule associated protein tau gene (MAPT), granulin precursor (GRN), and hexanucleotide repeat expansions in chromosome 9 open reading frame 72- SMCR8complex subunit (C9orf72) while mutations in other genes such as optineurin (OPTN) have rarely been reported. Mutations in OPTN have been reported mostly in familial and sporadic cases of ALS, or in rare cases of FTD-ALS, but not in association with pure or predominant FTD and/or parkinsonian phenotype. Here, we report for the first time, a family from the Philippines with four members harboring a novel frameshift insertion at OPTN (Chr 10:13166090 G>GA) p.Lys328GluTer11, three of whom presented with FTD-related phenotypes. Additionally, one sibling heterozygous for the frameshift insertion had a predominantly parkinsonian phenotype resembling corticobasal syndrome, but it remains to be determined if this phenotype is related to the frameshift insertion. Notably, none of the affected members showed any evidence of motor neuron disease or ALS at the time of writing, both clinically and on electrophysiological testing, expanding the phenotypic spectrum of OPTN mutations. Close follow-up of mutation carriers for the development of new clinical features and wider investigation of additional family members with further genetic analyses will be conducted to investigate the possibility of other genetic modifiers in this family which could explain phenotypic heterogeneity. Frontiers Media S.A. 2021-05-19 /pmc/articles/PMC8170397/ /pubmed/34093394 http://dx.doi.org/10.3389/fneur.2021.645913 Text en Copyright © 2021 Dominguez, Yu, Tan, Ng, De Guzman, Natividad, Daroy, Cano, Yu, Lian, Zeng, Lim, Foo and Ng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Dominguez, Jacqueline
Yu, Jeryl Tan
Tan, Yi Jayne
Ng, Arlene
De Guzman, Ma Fe
Natividad, Boots
Daroy, Ma Luisa
Cano, Jemellee
Yu, Justine
Lian, Michelle M.
Zeng, Li
Lim, Weng Khong
Foo, Jia Nee
Ng, Adeline S. L.
Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis
title Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis
title_full Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis
title_fullStr Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis
title_full_unstemmed Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis
title_short Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis
title_sort novel optineurin frameshift insertion in a family with frontotemporal dementia and parkinsonism without amyotrophic lateral sclerosis
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170397/
https://www.ncbi.nlm.nih.gov/pubmed/34093394
http://dx.doi.org/10.3389/fneur.2021.645913
work_keys_str_mv AT dominguezjacqueline noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis
AT yujeryltan noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis
AT tanyijayne noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis
AT ngarlene noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis
AT deguzmanmafe noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis
AT natividadboots noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis
AT daroymaluisa noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis
AT canojemellee noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis
AT yujustine noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis
AT lianmichellem noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis
AT zengli noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis
AT limwengkhong noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis
AT foojianee noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis
AT ngadelinesl noveloptineurinframeshiftinsertioninafamilywithfrontotemporaldementiaandparkinsonismwithoutamyotrophiclateralsclerosis